Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma.
Vallés-Martí A, Mantini G, Manoukian P, Waasdorp C, Sarasqueta AF, de Goeij-de Haas RR, Henneman AA, Piersma SR, Pham TV, Knol JC, Giovannetti E, Bijlsma MF, Jiménez CR.
Vallés-Martí A, et al. Among authors: piersma sr.
Cell Rep. 2023 Jun 27;42(6):112581. doi: 10.1016/j.celrep.2023.112581. Epub 2023 Jun 2.
Cell Rep. 2023.
PMID: 37269289
Free article.